Omnes Capital

VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

Novaled AG is a leading technology provider specializing in organic light-emitting diode (OLED) technologies. Founded in March 2003 and headquartered in Dresden, Germany, the company develops high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers comprehensive solutions for the organic electronic markets, including customized OLED products and services used in various applications, such as televisions and mobile phones. The company has established long-term partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled has branch offices in Asia to support its global operations.

DxO, established in 2002 and headquartered in Boulogne, France, specializes in the development and sale of digital image processing products and solutions. Its primary offerings include DxO Optics Pro, a software application for image correction and enhancement, and DxO FilmPack, which gives digital images the style of conventional films. Additionally, DxO licenses its intellectual property of optics and silicon architectures for embedded still and video image processing in camera phones and digital cameras. The company also provides DxO Analyzer, an image quality evaluation solution. DxO serves a diverse range of customers, from consumer electronics manufacturers to photographers and imaging experts, distributing its products through resellers and distributors.

Novaled AG is a leading technology provider specializing in organic light-emitting diode (OLED) technologies. Founded in March 2003 and headquartered in Dresden, Germany, the company develops high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers comprehensive solutions for the organic electronic markets, including customized OLED products and services used in various applications, such as televisions and mobile phones. The company has established long-term partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled has branch offices in Asia to support its global operations.